This paper is dedicated to the memory of our colleague, the late Professor Cathy Charles, who made a major contribution to the TRIO conceptual framework.
Introduction
Family caregivers regularly attend cancer consultations with an adult patient (accompaniment rates range from 64-86%) [1, 2] . Typically one key family caregiver attends, and this is usually the patient's spouse/partner or adult child (less commonly a patient's parent, sibling, other relative or friend) who is involved in the care of the patient [3] . This key family caregiver also often participates in the decision-making (DM) process [4] -some in a supportive or facilitative capacity, while others are involved more directly in DM.
The involvement of family caregivers in DM may be particularly important among some families, as medical decisions often impact not only the patient, but also the family caregiver [5, 6] . For example, the spouse of a young adult patient is likely to be directly impacted by a decision to undergo treatment which affects fertility. Correspondingly, daily life will be affected for the adult child caregiver of an elderly patient who decides to receive daily outpatient treatment requiring transportation and accompaniment to the hospital. Finally, family caregivers will be impacted by a decision for the patient to receive home-based palliative care and die at home. Despite the frequent involvement of family caregivers in consultations and decisions, most conceptual papers discussing medical DM published to date have focused on the clinician-patient dyad [see 7] rather than the clinician-patient-family caregiver triad and larger social networks. However, a growing empirical literature acknowledges the significant role of family caregivers in medical DM.
Most cancer patients (49-84%) and family caregivers (54-59%) report both preferring and experiencing some family caregiver involvement in DM [8] [9] [10] [11] [12] . However the form and extent of family involvement in DM appears to vary widely. Most patients and family caregivers prefer family caregivers' involvement to be facilitative or collaborative [9, 12] , and this preference is reflected in practice. In a US study examining the experiences of over 5,000 patients with lung and colorectal cancer, 1.5% of the sample reported their family made important decisions on their behalf, 49.4% reported equally sharing decisions with family, 22.1% reported some family involvement, and 28.5% of patients reported little or no role for their family in DM. Interaction analyses of audio/video-taped medical consultations similarly highlight that family caregivers are often actively involved in consultation communication [e.g. 2, 13] , and DM [13] [14] [15] ; and also reveal that family caregiver involvement in DM is variable both across consultations and among different triads [13] . Family caregiver involvement in DM can vary on a spectrum from passive to dominant [4, 16, 17] and the form/extent of involvement may be influenced by contextual factors such as the patient's age, gender, health status, cultural background and relationship with the family caregiver [11, 18] . Despite the growing empirical evidence base, there remains limited conceptual description of family caregiver involvement in DM.
Conceptual frameworks of family caregiver involvement in DM
Whilst the majority of conceptual publications to date have focused on the clinician-patient dyad, some more recent publications have started to acknowledge the importance of significant others, including family caregivers. For example, Rapley's [19] A limited number of more specific conceptual descriptions of family caregiver involvement in DM have also been published. These conceptual descriptions have predominantly been typologies based on qualitative data, which describe how family caregiver involvement in the DM process varies along a spectrum from passive to dominant [16, 17, 23, 24] . Two triadic process models have also been proposed [25, 26] , which posit how triadic interactions and patient outcomes (e.g.
satisfaction,
knowledge, and adherence) are influenced by factors including patient/family/clinician personality, knowledge, and attitudes. However, these existing descriptions do not capture the complex interactions and dynamics of all three participants (physician-patient-family caregiver) in the DM process.
The issues with 'ideal' or 'gold standard' DM styles when caregivers are involved
Besides Krieger [27] , who proposed that aligned patient-family caregiver preferences for the extent of caregiver involvement in DM are preferable, there has been little prescription of 'ideal' or 
Aims
To address persistent gaps in the conceptual literature, this paper proposes an empirically grounded framework of DM involving TRiadic Interactions in Oncology (TRIO Framework), which specifically aims to: i) depict the accommodation of family caregivers into the existing conceptualisation of clinician-patient DM; ii) explore the possible range of family caregiver influence over medical decisions and iii) describe the complexity and variability of family caregiver involvement in DM.
Scope and purpose of the TRIO Framework
The TRIO Framework focuses on the common scenario of one cognitively competent adult cancer patient, one key clinician (usually, but not restricted to, an oncology physician), and one key adult family caregiver (a person related to the patient biologically, legally, or emotionally, usually accompanying the patient to medical consultations and assisting in the patient's care). The purpose of the TRIO Framework is to help characterise the involvement of family caregivers, and purposefully does not propose any ideal or preferred style of family caregiver involvement in DM.
This Framework was developed based on cancer treatment DM, but is likely generalisable to other similar medical contexts.
Methods

Conceptual framework development
In this paper, a conceptual framework is defined as "a network, or a plane, of interlinked concepts that together provide a comprehensive understanding of a phenomenon" [32] . While the TRIO Framework development process was iterative and flexible in nature, it largely followed the eight main phases of conceptual framework development outlined by Jabareen [32] .
Phases 1-2:
Mapping the selected data sources (Phase 1) was achieved through conducting a systematic review of empirical studies examining clinician-patient-family caregiver communication and DM [33] as well as reviewing relevant conceptual, ethical, and legal perspectives on family caregiver involvement in DM [34] . Relevant data from qualitative interviews with oncology clinicians, patients, and family caregivers [4] and interaction analyses of triadic consultation audiotapes [13] , were also appraised. 
Results
The TRIO Framework
At the core of the TRIO Framework are six important conceptual insights (Concepts) derived from our program of empirical research and the wider evidence base. They include: The empirically-derived conceptual insights, which underpin the TRIO Framework, will be further described throughout this paper, with some being graphically conveyed using a triangle (the TRIO Triangle) to aid readers' understanding. A triangle (see Figure 1 ) was chosen as it accommodated the triadic nature of DM between the patient, key clinician, and key family caregiver. Triangles have previously been used to convey the clinician-patient-family relationship [see 36]. The TRIO Triangle should be considered as a tool to understanding some aspects of the wider and more comprehensive TRIO Framework.
Family caregiver Influence: Development of the TRIO Triangle
Within the clinician-patient dyad, influence over a medical decision is often presented as varying along a spectrum, ranging from 'paternalism' (clinician-led DM) to the 'informed' approach (patient-led DM). Shared DM between the clinician and patient has commonly been placed in the 'middle' of these two 'anchor points' [e.g. 37]. However it is clear that a family caregiver could not fit along this unidimensional line. Our [4, 13] and others' [e.g. 4, 13, 16, 17] empirical work points to the fact that, in many cases, a family caregiver is influential in the DM process, and their influence over a decision can similarly rest on a spectrum from passive, to shared, to dominant.
Based on this we propose that, instead of a unidimensional line (see Figure 1 , Section 1), a triangle is a more appropriate starting point to capture and express the complex scope of clinician-patientfamily caregiver influence over a decision (see Figure 1 , Section 2). It is proposed that each of the three points of the triangle represent the dominant influence of a specific individual during a DM interaction (e.g. clinician-led DM; patient-led DM; or family caregiver-led DM).
The TRIO Triangle also depicts the dyadic sharing of influence over a decision between two parties at the midpoint between two points of the triangle (i.e. shared clinician-patient DM; shared clinician-family caregiver DM; shared patient-family caregiver DM). The triadic 'equal' sharing of a decision between all three parties is located at the very centre of the triangle space (i.e. triadic DM between the patient, key clinician, and key family member) (see Figure 1 , Section 3). The positioning of the clinician at the apex of the triangle was purposeful, given that they typically hold dual roles within triadic DM, namely: i) as a participant within the DM process and ii) as the facilitator of triadic DM discussions within consultations, having the medical expertise and a professional role in the DM process.
An important point raised by Charles et al. [37] was that, in reality, clinician-patient DM does not exist only in these 'pure' or 'extreme' approaches (i.e. paternalistic approach, shared approach, informed approach). Rather, a multitude of intermediate/hybrid approaches exist along the unidimensional line. Similarly, we propose that real clinician-patient-family caregiver influence over a decision is likely to rest somewhere within the triangle space as an intermediate/hybrid approach existing within a spectrum (see Figure 1 , Section 4), versus the 7 "pure" approaches depicted by the points and mid-points of the triangle.
A comment on influence vs. involvement
The TRIO Triangle and Concepts 1 (family caregiver influence over a decision is variable amongst different groups) and 2 (family caregiver influence is variable within the one triad over time) discuss and depict the notion of family caregiver 'influence', that is, lead contributions to the shaping of the medical decision. Influence is conceptualized in the Triangle as being relative, where the more influence one party has-the less influence the others can have over a decision. There can, however, be points of equilibrium and sharing of influence, which are denoted in the TRIO Triangle as shared dyadic and shared triadic DM.
Whilst family caregiver influence is the primary focus of the TRIO Triangle and Concepts 1 and 2, in other elements of the Framework we acknowledge (and where possible comment on) the wider concept of family involvement in the DM process. Involvement in DM can manifest in varied ways, including the more obvious/concrete family caregiver involvement in information exchange (e.g.
researching treatments, providing information, questioning options) and deliberation (e.g.
providing an opinion, explicitly stating support of patient preferences), but also in more subtle/abstract ways as proposed by Entwistle and Watt [38] , such as a 'sense of being a part of' a decision, a 'commitment to being there for' the patient during DM, or 'being significantly impacted by' the decision. The broader concept of family caregiver involvement will be discussed in Concepts 3-6.
[
The six empirically-grounded conceptual insights (Concepts) that form the core of the TRIO Framework will now be outlined in detail.
Concept 1: Family caregiver influence over a decision is variable amongst different groups
An important empirical finding within the evidence base [4, 13, 16, 17] was the variability of family caregiver influence among triads. For example, in some cases the family caregiver was very passive and did not influence the decision whilst the patient and clinician shared the decision; in other triads, the family caregiver assumed a dominant role in DM while the patient and clinician had limited input.
"So there are times when patients will actually say, "Look, just ask him", or, "Ask her, I just don't feel like I can make another decision". So it really depends where they're at---" Nurse [4] . [INSERT FIGURE 2 HERE]
Concept 2: Family caregiver influence is variable within the one triad over time
In addition to among-triad variability, existing empirical literature points to the dynamism of family caregiver involvement within the one triad over time. For example, patients in our qualitative study reported that their family caregiver's influence over decisions evolved throughout the illness trajectory, where sometimes caregivers were required to take a more influential role in the DM process, and at other times they assumed a more passive role, as the patient's needs and abilities fluctuated over time [4] , thus, the role of a family member:
"will vary in the situation and it might vary even at different consultations. … It's a moveable dynamic". [4] To highlight the changing nature of family caregiver influence over decisions within the one triad, a case example is provided in Figure 3 , where points A, B, C, D, and E represent different decision points within one patient's illness trajectory.
[INSERT FIGURE 3 HERE]
Concept 3: Family caregivers are involved, in various ways, in the wider DM process
As highlighted in Concepts 1 and 2, family caregivers may exert influence over the decision to be implemented, and this level of influence may differ amongst different triads and within the one triad over time. In addition, our research has found that family are commonly involved in the DM process in many ways across the various stages of DM [4] . See Table 1 for supporting quotes.
For example, family caregivers may be involved in: i) pre consultation preparation (e.g.
researching which doctor to see, reading results of scans, preempting treatment options and discussing these with the patient); ii) information exchange (e.g. gathering/contributing information about treatments; asking questions; recalling information; providing medical information about the patient; providing social information about the patient/ themselves; questioning information provided by the clinician); and iii) deliberation (e.g. acting as a 'sounding board'; supporting and advocating for the patient's wishes; undermining the patient's preferences;
providing own opinions/preferences). It is through these behaviours/actions that family caregivers often exert influence over a decision, which can be perceived as positive, negative, or neutral contributions to the DM process. In addition, some of these family caregiver actions may also achieve other outcomes such as providing the patient with comfort and support, enhancing (or undermining) the patient's autonomy, and/or reassuring the clinician that the patient has had adequate support when making a decision. 
Concept 4: DM is not only amongst three
One patient, one key clinician, and one key family caregiver were the most commonly reported participants involved in consultations and DM discussions in our series of qualitative studies [3, 4, 39] . However, the wider 'social networks' of each of these key stakeholders may also be involved in the DM process and influential over the final decision, including other patients, family members, health professionals, friends, and neighbours [17, 40] . In addition, a growing body of evidence is recognising that clinicians also exist within interprofessional networks, and other clinicians, allied health team members, and healthcare administrators may inform the clinician's position within the DM process [41] [42] [43] . Indeed, the involvement of other health professionals is well documented in situations where complex medical decisions are discussed at multidisciplinary team meetings [e.g.
44].
These findings align with Epstein and Street's [20] concept of 'shared mind' decision processes, particularly the notion that decisions are made within social networks. Recognising that patients often discuss decisions with trusted family, friends, and clinicians before and after consultations,
Epstein [45] proposed that it is important to recognise these complex social networks and how they can affect DM, as their involvement and influence may not be outwardly apparent, particularly in the consultation environment. Figure 4 depicts a sociogram, a simplified version of a social network analysis which depicts hypothetical interrelationships among networks of key individuals [46] . More specifically, it highlights that, while there is usually a core 'triad' of individuals involved in a decision, many other individuals may exist within a wider social network. In Figure 4 , the patient and family caregiver networks are purposefully intertwined, as it is likely they will share a number of influential family members and friends.
[INSERT FIGURE 4 HERE]
Concept 5: Many factors may affect the form and extent of family caregiver involvement in DM
A number of factors (e.g. demographic, psychological, relational, cultural, and medical) may impact on the type of involvement family caregivers assume and the level of influence they have over a decision. See Table 2 for supporting quotes from our qualitative study [4] . [18] . Oncology clinicians in our groups' qualitative study also proposed that family caregivers may assume a greater role in DM when the patient was younger or older (rather than middle aged) and/or had a lower level of education while more actively involved caregivers tend to be middle aged, female, and well-educated [4] .
Psychological characteristics of participants, such as their mental health, coping, and personality traits may also impact upon the extent of family caregiver involvement. For example, Street and
Gordon [2] found a non-significant trend for family caregivers of patients reporting better mental health to be less active in the consultation, and in our work [4] , oncology clinicians reported that for patients with mental illness such as depression or anxiety, or with 'withdrawn' personalities, family caregivers had greater involvement and influence over decisions. These oncology clinicians posited that such psychological characteristics increased patient vulnerability, and made it more difficult for them to self-advocate or speak up in consultations. Other literature suggests that psychological empowerment correlated with older adults' preferred and perceived involvement in medical decision-making [47] .
The history and general nature of the relationship between participants, particularly between the patient and family caregiver, may also impact on the level of caregiver involvement and their subsequent influence. For example, family caregiver involvement in DM is increased among married/de-facto patient-caregiver pairs compared to other caregivers [11, 18] , and when caregivers report a close and strong relationship with the patient [4] .
Cultural and societal factors, such as cultural norms or language ability, may also impact on the extent that family caregiver input is desired and considered appropriate. For example, it has been found that families were typically more involved and influential if the patient was of Chinese decent [18] or if the caregiver or patient was a migrant from a non-English speaking country [4] . Social support provided to the family caregiver by others in the wider circle may also influence caregiver capacity to be involved in decision-making [48] .
The nature and severity of the disease may also influence family caregiver involvement. Family caregivers are more likely to be involved in DM for patients with more severe/advanced illnesses (e.g. advanced cancer) compared to milder or more short-term illnesses/injuries (e.g. ear infection) [11, 49] .
Finally, the nature and significance of the decision may influence the extent of family caregiver involvement. Oncology clinicians proposed that family caregivers may be more involved when the decision is complex, significant, or when the caregiver is heavily impacted by the decision [4] Empirical work by our group in Australia [4] highlights that family caregivers can assume a range of roles within and beyond the medical consultation (e.g. provision of emotional support, assistance with information, transportation, medication management, home-based medical care, assistance with activities of daily living, financial support). These, and the many other roles, which family caregivers may assume throughout a patient's illness, may foster and be examples of the more subtle types of involvement in a decision, as proposed by Entwistle and Watt [38] , which may be considered as valuable contributions to patient care in their own right, as well as potentially influencing the DM process in an indirect manner.
Discussion and conclusion
Discussion
The TRIO Framework provides the first comprehensive description of family caregiver involvement in, and influence over, cancer treatment decisions. It has been rigorously developed, informed by our own program of research [4, 13, 33] ; as well as a comprehensive review of other relevant empirical, conceptual, ethical, and legal publications, and iterative feedback from an advisory group of experts in ethics, medical oncology, psychology, and theory development. These strong empirical foundations underpinning the TRIO Framework enhance the validity and clinical relevance of the TRIO Framework, with several empirical examples derived from our interview [4] and consultation transcript [13] studies used to test the Framework's effectiveness in depicting the real behaviours and dynamics occurring during triadic DM.
A key strength of the TRIO Framework is that the focus on family caregivers is explored in the wider context of the clinician-patient-family caregiver triad. Through use of conceptual insights and graphical aids (TRIO Triangle), the TRIO Framework is able to describe some of the complex interactions and dynamics of all three core participants (patient, key clinician, key family caregiver) in the triadic DM process. More specifically, the TRIO Framework describes a number of empirically-grounded conceptual insights relating to family caregiver influence and involvement in the DM process, such as the variability of caregiver influence within and among groups, the wider social networks (beyond the triad) involved and invested in the DM process, the array of contextual factors which may affect the extent of caregiver involvement in DM, and the interrelationship between caregivers' roles in everyday illness management and DM.
The TRIO Framework has purposefully examined both the narrower concept of family caregiver influence over a decision, as well as the broader concept of family caregiver involvement in the DM process, including information exchange, deliberation and making the actual decision. These concepts were purposefully teased apart to highlight the many roles and impacts family caregivers have when involved in DM. In some cases, family caregiver involvement in DM is clearly linked to their level of influence over the final decision. For example, the wife of a prostate cancer patient researches which cancer treatment centre her husband should attend, provides him with information about the cancer and potential treatments, actively engages in the consultation discussions, and clearly articulates her preferences for a particular course of treatment, while the patient listens to his wife, takes into account all of her recommendations, and decides to receive the treatment she advocates. However, in many cases, family caregivers may be heavily involved in the DM process, but have limited influence over the final treatment to be implemented. For example, the adult son of a breast cancer patient researches and provides information about treatment options, attends consultations, acts as a sounding board when the patient is deliberating over the decision, and helps arrange the logistal aspects of her treatment, while the patient strongly believes it is "her body, her decision" and makes the decision for treatment independent of her son's preferences. This approach to family caregiver involvement in DM was commonly discussed by participants in our groups' qualitative study [4] , with one family caregiver stating Therefore, it is important for researchers and clinicians to not only consider the extent of family influence over the decision that a patient may prefer, but also the type and amount of family involvement in the broader DM process.
The TRIO Framework is likely to be useful in several ways. First, it provides an empirically-based platform for depicting the scope of triadic influence in medical DM, and may be a useful guide for further research in the area. Indeed, the TRIO Triangle itself could be conceptualised as a map to help understand the complex landscape of the family caregiver's relative influence over a decision.
For example, it may form the basis of ethical,legal, and clinical discussions debating whether some areas of the triangle are preferable in certain contexts (e.g. for patients with dementia, adolescent patients, fertility treatment DM) and when approaches taken by any member of the triad conflicts with that taken by another member, such as an assertive patient encountering a paternalistic physician or a caring but misguided family caregiver tries to direct a patient's choice.
In addition, by depicting a spectrum of family caregiver influence in DM, the TRIO Framework could be used to educate health professionals about the diverse and varying scope of family caregiver involvement and influence. This Framework also highlights that, in reality, there are many intermediate and nuanced styles that lie between the seven 'pure' styles. The identification of intermediate styles increases options for clinicians when they are discussing family caregiver involvement with patients (and potentially caregivers). Additionally, the point that DM styles may vary across an illness experience reinforces the importance of flexibility so that clinicians are able to recognise and respond to the evolving preferences and behaviours of patients and family caregivers over time. The identification of influencing factors also highlights that one factor (e.g. patient age or culture) is unlikely to solely influence the extent of family caregiver involvement; rather a complex web of factors are likely to influence DM styles. Clinicians should thus avoid assumptions based on a single characteristic of the patient or caregiver (e.g. all wives want to be heavily involved in DM). With further research and validation, a simplified form of the triangle could be useful in obtaining patient and/or family caregiver preferences for triadic DM dynamics.
As highlighted in Concept 6, a family caregiver's involvement in DM may be underpinned by their broader participation in the everyday care and management of the patient's illness, such as emotional support, practical/logistical support, and home-based medical care. Indeed, many of the conceptual insights in the TRIO Framework, such as Concept 1 (family caregiver influence over a decision is variable among groups), Concept 2 (family caregiver influence is variable within the one triad over time), and Concept 5 (many factors may affect the form and extent of family caregiver involvement in DM) apply not only to the narrower concept of treatment DM, but to many aspects of the much broader concept of illness care and management. For example, the amount and type of home-based medical care a family caregiver provides is likely to vary throughout the course of an illness (e.g. more active caregiver involvement during flare-ups) and is likely to be influenced by a number of contextual factors (e.g. the nature/closeness of the patient-family caregiver relationship, cultural expectations about caregiver roles).
Whilst the TRIO Framework focuses on family caregiver involvement when a patient is cognitively competent, many of the conceptual insights may also apply in situations where a patient has impaired cognitive capacity (e.g. early stage dementia, mild intellectual disability). Cognitive capacity should not be thought of as a dichotomous construct, but rather a more complex construct existing along a continuum from low to high cognitive ability, varying depending on the complexity of the decision, and able to fluctuate over time [e.g. 53]. Indeed, it has been argued that seriously ill (but legally cognitively competent) patients are also often cognitively compromised in subtle waysfacing a potentially terminal illness can result in cognitive biases and difficulty assimilating complex 
Limitations
The TRIO Framework characterizes important aspects of family caregiver involvement in DM,
however it also has some limitations. As the TRIO Triangle focuses on the core 'triad' (patient, key clinician, key family caregiver), it would need to be expanded to adequately represent more complex situations and those involving larger social networks, such as when there are two or more family caregivers who occupy important roles. Further development of the TRIO Framework will be needed to capture more complex relationship dynamics among the parties in the triad such as conflicts, undue family influence, and coalition formation.
Conclusion
This paper proposes the TRIO Framework, which provides an expanded representation of medical DM styles, accommodating the influence and involvement of family caregivers. We believe that this conceptual framework will help to guide future DM research, and also to deepen health professionals' and researchers' understanding of the array of possible triadic DM dynamics, inside and outside the consultation. Given the many (practical, theoretical, ethical, legal) complexities of triadic DM, our conceptualisation and articulation of family caregiver involvement in the DM process, and their ultimate influence over the decision to be implemented, is likely to continue to evolve based on emerging evidence and new perspectives. Starting from the dyad The starting point of our graphical conceptualisation of DM was the dyadic (clinician-patient) spectral line, with clinician-led DM (paternalistic approach) at one extreme, patient-led DM (informed approach) at the other extreme and shared clinician-patient DM (shared DM approach) depicted as the black dot in the middle.
However, our team perceived limited space for caregivers on this line, and therefore expansion was deemed necessary.
Expanding the clinician-patient
conceptualisation to include caregivers Our team proposes that a triangle best depicts the dynamics of the clinician, patient, and key family caregiver influence over a decision. In this graphical depiction, each anchor point (black dot) of the triangle represents an 'extreme' or 'pure' position, where one party has dominant influence over a decision.
Introducing shared approaches within a triad
Just as shared DM can be positioned at the midpoint of the clinician-led and patient-led approaches in dyadic DM (see section 1), so too can shared approaches be positioned within the midpoints of the TRIO Triangle. It is important to note that just because all three parties have the potential to exert influence over a decision, it does not mean that they will do so. Therefore, the three mid-line points on the TRIO Triangle represent three-types of dyadic shared DM that might exist when three parties are involved (clinician-patient; clinician-caregiver; or patientcaregiver).
In addition, the midpoint in the triangle space represents the sharing of DM influence between all three parties, representing shared triadic (clinicianpatient-caregiver) DM.
However, in reality, it is unlikely that any of these 7 depicted approaches exist in their pure form. Like Charles et al. [48] proposed, DM in the real world will be a more complex hybrid mix of these theoretical extremes.
Patient-led:
"Informed" approach 
Patient-led
Shared triadic
Caregiver influence as a spectrum
We propose that, in the real world, the dynamics of influence over a decision between a patient, key clinician, and key family member are likely to rest somewhere within the triangle space as an intermediate style. It is conceptualised that DM when a caregiver is present rests on a triadic spectrum which can shift from dominant influence of one individual (triangle point-e.g. clinician-led DM) to complete triadic sharing of the decision (triangle centre-shared triadic DM). The influence of a caregiver in DM may rest in any position within this triangle space. Example 2: is plotted at a point which represents that the patient has greatest influence over the decision (as indicated by the shortest distance on the arrow leading from the patient-led anchor point), followed by the caregiver with limited input of the clinician. 
Clinician-led
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